News

0

Noventure grants Pharmaforce exclusive distribution right for its product Tasectan® AF in the countries Denmark, Sweden, Finland and Norway.

Noventure grants Pharmaforce exclusive distribution right for its product Tasectan® AF in the countries Denmark, Sweden, Finland, and Norway. Tasectan® AF is intended to restore the physiological functions of the intestinal walls. It is specifically formulated for the control and reduction of the symptoms related to diarrheal events of different etiologies in adults and children.

Read more

Press Release: Noventure acquires Ulkox® and Oleoabrax®, two medical devices based on patented new wound-healing technology

• Acquisition allows Noventure to maintain focus on medical devices and grow therapeutic areas in which it operates • Medical devices contain Olea Europaea leaf extract, showing healing properties for ulcers and skin wounds • Innovative products are CE marked and available for licensing worldwide Barcelona, Spain, April 19, 2021 – Noventure, specialized in licensing innovative substance-based medical devices and specialist food supplements, today announces it has acquired the Ulkox® and Oleoabrax® products, based on an Olea Europaea leaf extract wound-healing technology.

Read more

Let's meet in..

2021, Oct 05

Vitafoods

Read more

2022, Feb 01

EWMA

Read more